Atlas Trials

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer

Clinical trial NCT00361231 · COMPLETED

Trial details

NCT number
NCT00361231
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Biliary Tract CancerGallbladder Adenocarcinoma
Start date
2006-05-01
Primary completion
2009-03-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.